Abi Manesh
Overview
Explore the profile of Abi Manesh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Veeraraghavan B, Shin E, Bakthavatchalam Y, Manesh A, Dubey D, Tascini C, et al.
Antimicrob Agents Chemother
. 2025 Mar;
:e0162724.
PMID: 40035550
In the ATTACK Phase 3 trial examining the efficacy of sulbactam (SUL)/durlobactam (DUR) to treat primarily complex (ABC) infections, imipenem (IPM)/cilastatin was added as a common therapy to both the...
2.
Daniel B, Inbaraj L, Kumaravadivelu S, Subramanian K, Ramraj B, Manesh A
Infect Dis Ther
. 2025 Jan;
14(2):317-325.
PMID: 39752122
Tuberculous meningitis (TBM) disables more than a third of its sufferers. Recent research has focused on optimizing the antitubercular regimen, mainly by increasing the dosage of rifampicin. However, pyrazinamide, with...
3.
Chacko B, Chaudhry D, Peter J, Khilnani G, Saxena P, Sehgal I, et al.
Indian J Crit Care Med
. 2024 Oct;
28(10):989.
PMID: 39411300
No abstract available.
4.
Manesh A, George M, Palanikumar P, Nagaraj V, Bhanuprasad K, Krishnan R, et al.
Infect Dis Ther
. 2024 Sep;
13(11):2351-2362.
PMID: 39322920
Introduction: International guidelines recommend definitive combination antibiotic therapy for the management of serious infections involving carbapenem-resistant Acinetobacter (CRAB) species. The commonly available combination options include high-dose sulbactam, polymyxins, tetracyclines, and...
5.
Chacko B, Chaudhry D, Peter J, Khilnani G, Saxena P, Sehgal I, et al.
Indian J Crit Care Med
. 2024 Sep;
28(Suppl 2):S67-S91.
PMID: 39234233
How To Cite This Article: Chacko B, Chaudhry D, Peter JV, Khilnani G, Saxena P, Sehgal IS, . isccm Position Statement on the Approach to and Management of Critically Ill...
6.
Freire M, Pouch S, Manesh A, Giannella M
Transpl Int
. 2024 Jul;
37:12469.
PMID: 38952482
Solid organ transplant (SOT) recipients are particularly susceptible to infections caused by multidrug-resistant organisms (MDRO) and are often the first to be affected by an emerging resistant pathogen. Unfortunately, their...
7.
Soni A, Rugbeer Y, Rozmiarek J, Manesh A, Marais S
Infect Dis Now
. 2024 Jun;
54(6):104941.
PMID: 38942293
Introduction: Spinal tuberculosis is often associated with poor outcomes; host-directed inflammation involving the spine contributes to this disability. Methods: A retrospective review of patients with complicated spinal tuberculosis having received...
8.
Manesh A, M Varghese G, Paterson D
N Engl J Med
. 2024 May;
390(20):1938.
PMID: 38810201
No abstract available.
9.
Abraham A, Manesh A, Regi S, Michael J, Kumar R, Thomas M, et al.
World Neurosurg X
. 2024 May;
23:100387.
PMID: 38746040
Objective: To describe clinicoradiological features and surgical outcomes in a series of nine patients with rhino-orbito-cerebral mucormycosis (ROCM) who presented with Pott's puffy tumor (ROCM-PPT). Methods: The records of nine...
10.
Inbaraj L, Manesh A, Ponnuraja C, Bhaskar A, Srinivasalu V, Daniel B
Trials
. 2024 May;
25(1):294.
PMID: 38693583
Background: Despite several incremental improvements in the management of tuberculous meningitis (TBM), the mortality rates remain high. In spite of national and international guidelines, variation in the choice, dose, and...